General Information
Version
1.0 en
Revision date
2025-03-31
Product name
ROTIPHORESE Gel B 2 %, gas-stabilized
REACH No
not
1.2.2. Uses advised against
Do not use for products which come into contact with foodstuffs. Do not use for private purposes (household). Food, drink and animal feeding- stuffs
Emergency telephone
+41 61 7121160
Icons in SDS
Company Information
company name
ROTH AG
e-mail address of the competent person responsible for the Safety Data Sheet
sicherheit@carlroth.de, info@carlroth.ch
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H340, H350, H373
Hazard statements
Code
Statements
H340
May cause genetic defects
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No 1272/2008 [CLP Classification of the substance or mixture
Hazard categories
Cat- Hazard class and Hazard egory category statement 3.5 Germ cell mutagenicity 1B Muta. 1B H340 3.6 Carcinogenicity 1B Carc. 1B H350 3.9 Specific target organ toxicity - repeated exposure STOT RE 2 H373 For full text of abbreviations: see SECTION 16
Most important adverse effects
Delayed or immediate effects can be expected after short or long-term exposure
Signal word
Danger Danger Not required
Hazard pictograms
GHS08 H340 May cause genetic defects. H350 May cause cancer. P280 Wear protective gloves/eye protection. P308+P313 IF exposed or concerned: Get medical advice/attention.
Hazard statements
H340 May cause genetic defects H350 May cause cancer H373 May cause damage to organs (peripheral nervous system) through prolonged or repeated exposure (if swallowed) Not required
Prevention
P260 Do not breathe gas/mist/vapours/spray P280 Wear protective gloves/eye protection
Response
P308+P313 IF exposed or concerned: Get medical advice/attention For professional users only
Hazardous Ingredients
N,N'-Methylene bisacrylamide Labelling of packages where the contents do not exceed 125 ml
Contains
N,N'-Methylene bisacrylamide Labelling of packages where the contents do not exceed 10 ml
Precautionary statements
Not required
Results of PBT and vPvB assessment
Does not contain a PBT-/vPvB-substance at a concentration of ≥ 0,1%. Endocrine disrupting properties Does not contain an endocrine disruptor (ED) at a concentration of ≥ 0,1%.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 (CLP) Section Hazard class Cat- Hazard class and Hazard egory category statement 3.5 Germ cell mutagenicity 1B Muta. 1B H340 3.6 Carcinogenicity 1B Carc. 1B H350 3.9 Specific target organ toxicity - repeated exposure 2 STOT RE 2 H373 For full text of abbreviations: see SECTION 16 The most important adverse physicochemical, human health and environmental effects Delayed or immediate effects can be expected after short or long-term exposure.
